Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07646522

Telerehabilitation and Biomarkers of Recovery After Stroke in Brazil

The purpose of this research study is to provide preliminary evidence of whether telerehabilitation targeting arm movement, when added to usual care, improves arm function and reduces global disability after stroke, compared to usual care alone in Brazil. Evaluate the safety and feasibility of telerehabilitation in the Brazilian context. Explore the clinical, neuroimaging, neurophysiological, and economic factors that influence telerehabilitation efficacy in functional recovery following stroke.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Ribeirão Preto Medical School, University of São Paulo

Ribeirão Preto, São Paulo, 14049900, Brazil

Location status: Recruiting

Location contact

Antonio Carlos dos Santos, MD, PhD

CONTACT

Antonio Carlos dos Santos, MD, PhD

SUB_INVESTIGATOR

Taiza G. S. Edwards, PhD

CONTACT

[email protected]

+5516-36021202

Taiza G. S. Edwards, PhD

PRINCIPAL_INVESTIGATOR

About this study

This is a two-arm phase II randomized controlled trial with blinded outcome assessment. A total of 20 post-stroke participants will be randomized to either telerehabilitation added to usual care (TR+UC) or usual care alone (UC). The primary outcome measure is the Action Research Arm Test (ARAT), which assesses upper extremity motor function. Secondary measures will include feasibility and intervention-related outcomes.

Study participation will span approximately 4 months and includes 6 in-person assessment visits. At these visits, participants will complete a battery of assessments, including upper extremity motor function tests, resting-state functional electroencephalography (EEG), and a single magnetic resonance imaging (MRI) scan of the brain. Participants assigned to the TR+UC group will receive structured arm motor training consisting of 36 sessions of prescribed exercises, interactive games, and stroke education delivered over 6 weeks at a frequency of 6 days per week, with each session lasting approximately 70 minutes. TR+UC participants will continue all usual care concurrently. Participants in the UC group will continue all therapies recommended by their medical team without participating in telerehabilitation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-80 years at the time of randomization.
  • The index stroke was radiologically verified, due to ischemia, and had time of onset 120±30 days prior to randomization.
  • The stroke caused upper extremity deficits as defined by Action Research.
  • Arm Test score 18-44 (out of 57) at Baseline Visit.
  • Box & Block Test score with affected arm is ≥1 block in 60 seconds at Baseline Visit.
  • Able to successfully perform all 3 rehabilitation exercise test examples (simple commands) at Baseline Visit.
  • Informed consent and behavioral contract signed by the subject (i.e., no surrogate consent).

Exclusion criteria

  • A major, active, coexistent neurological, psychiatric, or medical disease that reduces the likelihood that a subject will be able to comply with all study procedures.
  • Unable or unwilling to perform study procedures/therapy, or expectation of noncompliance with study procedures/therapy, or expectation that subject cannot participate in all study visits.
  • A diagnosis (apart from the index stroke) that substantially affects paretic arm function.
  • Severe depression, defined as Geriatric Depression Scale Score >10/15 at Baseline Visit.
  • Significant cognitive impairment, defined as Montreal Cognitive Assessment [a lower score can be permitted at the discretion of the PI].
  • Deficits in communication that interfere with reasonable study participation.
  • Severe UE spasticity, defined as presence of contracture or modified Ashworth Scale score=4 in either biceps or pectoralis.
  • Modified Rankin Scale score >2 prior to the index stroke.
  • A new symptomatic stroke has occurred since the index stroke, or a separate stroke occurred within 30 days prior to the index stroke.
  • Lacking visual acuity, with or without corrective lens, of 20/50 or better in at least one eye.
  • Life expectancy < 9 months
  • Pregnancy; women of child-bearing potential must have a negative pregnancy test.
  • Botulinum toxin to the paretic arm: received in the prior 3 months or expected by the 1-Month Visit.
  • Concurrent enrollment in another therapy-based investigational study where the duration of the investigational therapy's activity is likely to occur during the subject's participation in the study.
  • Subject lacks sufficient Portuguese to comply with study procedures and TR instructions.
  • Contraindication to MRI.
  • Contraindication to TMS.
  • Box and Block Test score of ≥30 blocks with the unaffected arm within 60 seconds at Baseline Visit;
  • Spatial neglect interfering with reasonable participation in the study;
  • On isolation precautions, e.g., due to active COVID-19.
  • Expectation that participant will not have a single domicile address during the 6 weeks of therapy.
  • Distance from the participant's home to the study site greater than 120 km [this can be waived at the discretion of the PI].
  • Availability of a 2 m² space for a table and chair setup.

Treatment and study plan

Telerehabilitation

Device

Participants will receive 36 telerehabilitation sessions targeting arm motor function in addition to their usual care. TR consists of 70 minutes/day of activities targeting arm function, 6 days/week for 6 weeks. Half of these sessions are supervised by a licensed therapist, and the other half are done independently.

Usual Care

Other

Usual care rehabilitation refers to the recommendations made by their care team.

Primary outcomes

  1. Change in Action Research Arm Test (ARAT) Score from baseline to the early post-intervention.

    Time frame: From baseline to early (within 7 days) post-intervention

    Change in Action Research Arm Test (ARAT) Score from baseline to the early post-intervention. The ARAT scale measures arm function using a scale that runs from 0 to 57 points, with higher numbers reflecting better arm function.

  2. Study feasibility in the Brazilian context - recruitment.

    Time frame: Through recruitment completion - an average of 15 months

    Proportion of eligible participants who agree to take part in the study.

  3. Study feasibility in the Brazilian context - adherence.

    Time frame: Through study completion (specifically end of therapy) - an average of 17 months

    Proportion of participants who complete TR therapy with sessions of 40 minutes or longer.

  4. Study feasibility in the Brazilian context - retention.

    Time frame: Through study completion (specifically end of follow-up) - an average of 18 months

    Proportion of dropouts during the study participation period.

Secondary outcomes

  1. Change in Action Research Arm Test (ARAT) Score from baseline to 1 month post-intervention.

    Time frame: From baseline to 1 month post-intervention

    Change in Action Research Arm Test (ARAT) Score from baseline to 1 month post-intervention. The ARAT scale measures arm function using a scale that runs from 0 to 57 points, with higher numbers reflecting better arm function.

  2. Treatment-related adverse events reported by the participants.

    Time frame: From the start of TR to early (within 7 days) post-intervention

    Number and severity of adverse events related to the telerehabilitation intervention reported by the participants.

Other outcomes

  1. White matter integrity assessed using diffusion tensor imaging (DTI) magnetic resonance imaging (MRI).

    Time frame: Baseline

    Cortical spinal tract integrity - lesion load (predictive factor).

  2. Interhemispheric connectivity of motor cortices assessed using resting-state functional magnetic resonance imaging (rs-fMRI).

    Time frame: Baseline

    rs-fMRI interhemispheric functional connectivity in the primary motor cortex (predictive factor).

  3. Motor cortex mapping and motor representation assessed using neuronavigated transcranial magnetic stimulation (nTMS).

    Time frame: Baseline

    nTMS motor mapping (predictive factor).

  4. Interhemispheric connectivity of motor cortices assessed using resting-state functional electroencephalography (rsEEG).

    Time frame: Baseline

    rsEEG interhemispheric functional connectivity in the primary motor cortex (predictive factor).

  5. Change in upper-extremity Fugl-Meyer assessment (UE-FM) from baseline to the early post-intervention.

    Time frame: From baseline to early (within 7 days) post-intervention

    Change in UE-FM. UE-FM is a scale that measures upper limb motor function using a scale that runs from 0 to 66 points, with higher scores reflecting better upper extremity motor function.

  6. Change in Modified Rankin Scale (mRS) from Baseline to the early post-intervention.

    Time frame: From baseline to early (within 7 days) post-intervention

    Change in mRS. The mRS scale measures global function using a scale that runs from 0 to 6 points, with lower numbers reflecting better global function.

  7. Change in interhemispheric connectivity of motor cortices assessed using resting-state functional electroencephalography (rsEEG).

    Time frame: From baseline to early (within 7 days) post-intervention

    Change in rsEEG interhemispheric functional connectivity in the primary motor cortex.

  8. Change in interhemispheric connectivity of motor cortices assessed using resting-state functional electroencephalography (rsEEG).

    Time frame: From baseline to 1-month post-intervention

    Change in rsEEG interhemispheric functional connectivity in the primary motor cortex.

  9. Change in motor cortex mapping and motor representation assessed using neuronavigated transcranial magnetic stimulation (nTMS) from baseline to early post-intervention.

    Time frame: From baseline to early (within 7 days) post-intervention

    nTMS motor mapping (predictive factor).

  10. Change in motor cortex mapping and motor representation assessed using neuronavigated transcranial magnetic stimulation (nTMS) from baseline to 1 month post-intervention.

    Time frame: From baseline to 1 month post-intervention

    nTMS motor mapping (predictive factor).

Study contacts

Contact information is provided by the study sponsor or research team.

Antonio Carlos Santos, MD, PhD

CONTACT

+551636022964

Taiza G. S. Edwards, PhD

CONTACT

[email protected]

+5516-36021202

Sponsors and collaborators

Lead sponsor

University of Sao Paulo

Other

Collaborators

  • Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School
  • Clinical Hospital, Ribeirão Preto Medical School, University of São Paulo
  • Ribeirão Preto Medical School, University of São Paulo
  • Thomas Jefferson University
  • University of California, Los Angeles

Registry information

Official study title

Telerehabilitation and Biomarkers of Functional Recovery After Stroke in Brazil: TR-BR-1 Clinical Trial

Acronym: TR-BR-1

Important dates

Study start
2026
Primary completion
2027
Study completion
2028
First posted
Jun 12, 2026
Registry last updated
Jun 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.